Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: £5.85 M
• Last 3 months FTD volume: £7.65 M
• Last 12 months FTD volume: £11.96 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Seagen SGEN	N/A	£3.02 M	🇺🇸 USA
Agenus AGEN	£0.39 M	£3.49 M	🇺🇸 USA
Emergent BioSolutions EBS	£1.89 M	£4.32 M	🇺🇸 USA
Amgen AMGN	£5.75 M	£0.21 B	🇺🇸 USA
Pfizer PFE	£24.63 M	£0.10 B	🇺🇸 USA
GlaxoSmithKline GSK	£72.01 M	£0.40 B	🇬🇧 UK
Titan Pharmaceuticals TTNP	£0.09 M	£0.36 M	🇺🇸 USA